Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy.
Freitas R, Ferreira E, Miranda A, Ferreira D, Relvas-Santos M, Castro F, Santos B, Gonçalves M, Quintas S, Peixoto A, Palmeira C, Silva AMN, Santos LL, Oliveira MJ, Sarmento B, Ferreira JA.
Freitas R, et al. Among authors: ferreira ja.
ACS Nano. 2024 Apr 9;18(14):10088-10103. doi: 10.1021/acsnano.3c12487. Epub 2024 Mar 27.
ACS Nano. 2024.
PMID: 38535625